THE importance we give to the day we honor the gallantry and sacrifices of our war veterans and the resources we allocate for ...

Scientists from Adelaide and the United States have found a surprising connection between a rare type of arthritis and gene ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

A Danish study finds that symptom interpretation and beliefs about treatment impact how quickly patients with early ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

New research highlights that frailty in patients with RA — young and old — raises infection risk and complicates treatment, ...

Inflammatory arthritis encompasses a group of autoimmune diseases, including rheumatoid arthritis (RA), psoriatic arthritis ...

Patients with LORA and CLD at baseline had lower rates of treatment response and a higher risk for SAEs over 5 years, compared against those without CLD.